Paradoxically, a reduction in common tirzepatide side effects like nausea, constipation , or digestive changes after a suspected heat event could indicate reduced potency
Between different vial strengths like 5mg, 10mg, or 15mg and various syringe sizes, the margin for error feels thin
Note that DPP-4 inhibitors should not be used concurrently with GLP-1 receptor agonists due to overlapping mechanisms
During your consultation, well discuss which medication is best for your goals, side effect tolerance, and budget
A large observational cohort study reported that nearly half of patients discontinued GLP-1 RA therapy within one year, with lower income significantly associated with discontinuation